11/8/24 16:53 | 11/6/24 | SYRE | Health | Drug | Pharmaceutical Preparations | Albers Jeffrey W. | MA | D | | S | -246 | 36.76 | 0 | -7 | -20 | 27 | I | | | | | | | | | | | | | | |
10/28/24 16:41 | 10/25/24 | SYRE | Health | Drug | Pharmaceutical Preparations | Albers Jeffrey W. | MA | D | | S | -11 | 36.43 | 0 | 0 | -1 | 34 | I | | | | | | | | | | | | | | |
9/5/24 16:04 | 9/3/24 | SYRE | Health | Drug | Pharmaceutical Preparations | Burrows Scott L | MA | O | CFO | S | -522 | 28.17 | 0 | -19 | -14 | 116 | D | | | | | | | | | | | | | | |
4/25/24 16:55 | 4/25/24 | SYRE | Health | Drug | Pharmaceutical Preparations | Fairmount Funds Management LLC | PA | D | | M.d | 0 | 0.00 | 0 | 3,640 | 306 | 4,830 | I | | | | | | | | | | | | | | |
8/25/22 19:37 | 8/25/22 | AGLE | Health | Drug | Pharmaceutical Preparations | Souza Marcio | TX | D | | P | 50 | 0.5608 | 0 | 90 | New | 90 | D | | | | | | | | | | | | | | |
6/10/22 18:24 | 6/8/22 | AGLE | Health | Drug | Pharmaceutical Preparations | Hanley Jr. Michael Conick | TX | O | Chief Co | P | 20 | 0.7100 | 0 | 28 | 353 | 36 | D | | | | | | | | | | | | | | |
3/18/22 06:46 | 3/16/22 | AGLE | Health | Drug | Pharmaceutical Preparations | Quinn Anthony G. | TX | DO | P,CEO | P | 188 | 2.34 | 0 | 80 | 11 | 817 | D | | | | | | | | | | | | | | |
3/15/22 18:32 | 3/11/22 | AGLE | Health | Drug | Pharmaceutical Preparations | Quinn Anthony G. | TX | DO | P,CEO | P.m | 281 | 1.94 | 0 | 145 | 24 | 740 | D | | | | | | | | | | | | | | |
3/15/22 18:30 | 3/11/22 | AGLE | Health | Drug | Pharmaceutical Preparations | Alspaugh Jonathan | TX | O | CFO | P | 156 | 2.08 | 0 | 75 | 83 | 165 | D | | | | | | | | | | | | | | |
12/13/21 20:41 | 12/9/21 | AGLE | Health | Drug | Pharmaceutical Preparations | Shanafelt Armen | TX | D | | P.m | 550 | 3.66 | 0 | 150 | New | 150 | D | | | | | | | | | | | | | | |
12/13/21 20:39 | 12/9/21 | AGLE | Health | Drug | Pharmaceutical Preparations | Quinn Anthony G. | TX | DO | P,CEO | P.m | 199 | 3.71 | 0 | 54 | 10 | 595 | D | | | | | | | | | | | | | | |
12/13/21 20:37 | 12/9/21 | AGLE | Health | Drug | Pharmaceutical Preparations | Alspaugh Jonathan | TX | O | CFO | P | 186 | 3.72 | 0 | 50 | 124 | 90 | D | | | | | | | | | | | | | | |
8/18/21 17:21 | 8/16/21 | AGLE | Health | Drug | Pharmaceutical Preparations | Alspaugh Jonathan | TX | O | CFO | P.m | 263 | 6.51 | 0 | 40 | New | 40 | D | | | | | | | | | | | | | | |
5/4/20 07:30 | 4/30/20 | AGLE | Health | Drug | Pharmaceutical Preparations | Quinn Anthony G. | TX | DO | P,CEO | P | 784 | 4.75 | 0 | 165 | 44 | 538 | D | | | | | | | | | | | | | | |
10/7/19 16:09 | 10/4/19 | AGLE | Health | Drug | Pharmaceutical Preparations | Quinn Anthony G. | TX | DO | P,CEO | M.d | 115 | 6.28 | 0 | 18 | 5 | 372 | D | | | | | | | | | | | | | | |
6/14/19 17:22 | 6/12/19 | AGLE | Health | Drug | Pharmaceutical Preparations | Quinn Anthony G. | TX | DO | P,CEO | P.m | 196 | 6.16 | 0 | 32 | 10 | 354 | D | | | | | | | | | | | | | | |
5/22/19 16:55 | 5/20/19 | AGLE | Health | Drug | Pharmaceutical Preparations | Quinn Anthony G. | TX | DO | P,CEO | P.m | 180 | 6.77 | 0 | 27 | 9 | 322 | D | | | | | | | | | | | | | | |
5/17/19 17:04 | 2/15/19 | AGLE | Health | Drug | Pharmaceutical Preparations | Quinn Anthony G. | TX | DO | P,CEO | P.m | 126 | 6.75 | 0 | 19 | 7 | 295 | D | | | | | | | | | | | | | | |
2/8/19 16:15 | 2/6/19 | AGLE | Health | Drug | Pharmaceutical Preparations | Quinn Anthony G. | TX | DO | P,CEO | M.d | 54 | 6.18 | 0 | 9 | 3 | 276 | D | | | | | | | | | | | | | | |
12/10/18 17:40 | 2/15/18 | AGLE | Health | Drug | Pharmaceutical Preparations | Quinn Anthony G. | TX | DO | P,CEO | P.dm | 21 | 7.05 | 0 | 3 | 1 | 268 | D | | | | | | | | | | | | | | |
12/10/18 17:40 | 12/7/18 | AGLE | Health | Drug | Pharmaceutical Preparations | Quinn Anthony G. | TX | DO | P,CEO | M.d | 752 | 4.37 | 0 | 172 | 179 | 268 | D | | | | | | | | | | | | | | |
9/28/18 17:11 | 9/27/18 | AGLE | Health | Drug | Pharmaceutical Preparations | Schuchart Aaron | TX | O | Chief Bu | S | -57 | 9.50 | 0 | -6 | -71 | 3 | D | | | | | | | | | | | | | | |
8/21/18 16:24 | 8/17/18 | AGLE | Health | Drug | Pharmaceutical Preparations | Schuchart Aaron | TX | O | Chief Bu | M.d | 30 | 3.50 | 0 | 9 | New | 9 | D | | | | | | | | | | | | | | |
8/15/18 16:40 | 8/13/18 | AGLE | Health | Drug | Pharmaceutical Preparations | Georgiou George | TX | D | | M.d | 221 | 5.91 | 0 | 37 | 27 | 176 | D | | | | | | | | | | | | | | |
7/16/18 09:04 | 7/12/18 | AGLE | Health | Drug | Pharmaceutical Preparations | Quinn Anthony G. | TX | DO | Interim | M.d | 263 | 6.76 | 0 | 39 | 72 | 93 | D | | | | | | | | | | | | | | |
7/13/18 09:05 | 7/11/18 | AGLE | Health | Drug | Pharmaceutical Preparations | Quinn Anthony G. | TX | DO | Interim | M.d | 18 | 5.46 | 0 | 3 | 7 | 54 | D | | | | | | | | | | | | | | |
5/14/18 16:01 | 5/11/18 | AGLE | Health | Drug | Pharmaceutical Preparations | Novartis Bioventures Ltd | V8 | T | | S | -197 | 10.06 | 0 | -20 | -1 | 2,175 | D | | | | | | | | | | | | | | |
5/11/18 16:28 | 5/9/18 | AGLE | Health | Drug | Pharmaceutical Preparations | Novartis Bioventures Ltd | V8 | T | | S.m | -748 | 10.12 | 0 | -74 | -3 | 2,195 | D | | | | | | | | | | | | | | |
5/9/18 16:01 | 5/7/18 | AGLE | Health | Drug | Pharmaceutical Preparations | Novartis Bioventures Ltd | V8 | T | | S.m | -424 | 10.06 | 0 | -42 | -2 | 2,269 | D | | | | | | | | | | | | | | |
2/20/18 16:36 | 2/15/18 | AGLE | Health | Drug | Pharmaceutical Preparations | Quinn Anthony G. | TX | DO | Interim | M.d | 83 | 5.46 | 0 | 15 | 43 | 51 | D | | | | | | | | | | | | | | |
12/8/17 19:06 | 12/6/17 | AGLE | Health | Drug | Pharmaceutical Preparations | Quinn Anthony G. | TX | DO | Interim | P.m | 41 | 4.96 | 0 | 8 | 31 | 35 | D | | | | | | | | | | | | | | |
12/5/17 21:07 | 8/15/16 | AGLE | Health | Drug | Pharmaceutical Preparations | York Charles N II | TX | O | CFO,VP | P.m | 116 | 4.48 | 0 | 26 | 294 | 35 | D | | | | | | | | | | | | | | |
12/5/17 21:04 | 12/1/17 | AGLE | Health | Drug | Pharmaceutical Preparations | Quinn Anthony G. | TX | D | | P.m | 83 | 4.86 | 0 | 17 | 171 | 27 | D | | | | | | | | | | | | | | |
2/21/17 17:58 | 2/16/17 | AGLE | Health | Drug | Pharmaceutical Preparations | Orbimed Advisors LLC | NY | T | | P.m | 564 | 5.16 | 1 | 109 | 8 | 1,470 | I | | | -11 | -13 | -1 | 30 | 24 | 1 | 7 | 7 | 37 | | | |
4/14/16 18:41 | 4/12/16 | AGLE | Health | Drug | Pharmaceutical Preparations | Lilly Eli & Co | IN | T | | P.d | 5,000 | 10.00 | 5 | 500 | 24 | 2,569 | I | | | | | | | | -16 | 2 | -12 | -23 | -50 | -28 | |
4/12/16 17:10 | 4/12/16 | AGLE | Health | Drug | Pharmaceutical Preparations | Quinn Anthony | TX | D | | P | 100 | 10.00 | 8 | 10 | New | 10 | D | | | | | | | | | 4 | 1 | -8 | -53 | -27 | |
4/12/16 17:09 | 4/12/16 | AGLE | Health | Drug | Pharmaceutical Preparations | Novartis Bioventures Ltd | D0 | T | | P.d | 3,000 | 10.00 | 8 | 300 | 15 | 2,311 | D | | | | | | | | | 4 | 1 | -8 | -53 | -27 | |
4/12/16 17:06 | 4/12/16 | AGLE | Health | Drug | Pharmaceutical Preparations | Cox Russell J. | TX | D | | P | 70 | 10.00 | 8 | 7 | New | 7 | D | | | | | | | | | 4 | 1 | -8 | -53 | -27 | |